ACRS · Aclaris Therapeutics, Inc.

$5.13 -0.20 (-3.75%)

Market Cap

$744.41M

139.66M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
Investor Event Transcript	2026-06-30	—
Investor Event Transcript	2026-06-30	—
8-K	2026-06-04	—
10-Q	2026-05-07	2026-03-31
8-K	2026-05-07	—
8-K	2026-04-28	—
DEF 14A	2026-04-23	2026-06-04
8-K	2026-03-11	2026-03-10
8-K	2026-03-10	2026-03-09
10-K	2026-02-26	2025-12-31
8-K	2026-02-26	—
8-K	2026-01-12	—
8-K	2026-01-06	—
10-Q	2025-11-06	2025-09-30
8-K	2025-11-06	—
8-K	2025-10-14	—
8-K	2025-08-07	—
10-Q	2025-08-07	2025-06-30
8-K	2025-07-29	—
8-K	2025-06-30	—
8-K	2025-06-05	—
10-Q	2025-05-08	2025-03-31
8-K	2025-05-08	—
DEF 14A	2025-04-24	2025-06-05
10-K	2025-02-27	2024-12-31
8-K	2025-02-27	—
8-K	2025-01-13	—
8-K	2024-11-18	2024-11-16
8-K	2024-11-06	—
10-Q	2024-11-06	2024-09-30
8-K	2024-08-07	—
10-Q	2024-08-07	2024-06-30
8-K	2024-07-16	—
8-K	2024-06-07	2024-06-06
10-Q	2024-05-07	2024-03-31
8-K	2024-05-07	—
DEF 14A	2024-04-25	2024-06-06
8-K	2024-03-19	2024-03-14
10-K	2024-02-27	2023-12-31
8-K	2024-02-27	—
8-K	2024-02-05	2024-01-31
8-K/A	2024-02-05	2024-01-15
8-K	2024-01-19	2024-01-15
8-K	2023-12-19	—
8-K	2023-11-13	—
8-K	2023-11-06	—
10-Q	2023-11-06	2023-09-30
8-K	2023-09-18	—
10-Q	2023-08-07	2023-06-30
8-K	2023-08-07	—

Showing 1–50 of 120 filings

Key facts CIK 1557746 CUSIP 00461U105 13F (30d) 18 filings 18 filers Visit website Investor relations